Group 1 - The company China Financial Leasing (02312) has announced that the conditions of the subscription agreement have been fulfilled, and the completion occurred on October 22, 2025, according to the terms and conditions of the subscription agreement [1] - A total of 69,379,500 subscription shares were issued at a subscription price of HKD 1.25 per share to the subscribers [1] - The subscription shares represent approximately 20% of the total issued shares before completion and approximately 16.67% of the total issued shares after the issuance of the subscription shares [1] Group 2 - The total amount raised from the subscription is approximately HKD 86.72 million, with a net amount of approximately HKD 86.43 million [1]

Core Viewpoint - Jin Jing New Energy (01783) has announced a subscription agreement with Vintage Antique Limited, involving the issuance of 50 million shares at a subscription price of HKD 3.10 per share, representing a 1.31% premium over the closing price on October 17 [1] Group 1 - The total amount expected from the subscription is HKD 155 million, with a net amount of approximately HKD 154.9 million after deducting all professional fees and related expenses [1] - The net proceeds are intended for sales cooperation projects and environmental park projects [1] - The shares to be issued represent about 1.78% of the total shares currently issued and approximately 1.75% of the total shares after the issuance [1]

Group 1 - The company, China Gas (08246), has announced that the conditions of the subscription agreement have been fulfilled and will be completed on October 17, 2025 [1] - A total of 334 million subscription shares will be issued, representing approximately 7.26% of the enlarged issued share capital of the company [1] - The subscription shares were successfully allocated and issued to the subscribers at a price of HKD 0.075 per share, with total proceeds amounting to HKD 25.05 million and net proceeds of approximately HKD 24.75 million [1]

Core Viewpoint - The company, Jixing New Energy (03395), has entered into a conditional subscription agreement to issue 11.16 million shares at a subscription price of HKD 0.31 per share, representing a discount of approximately 7.46% from the closing price on October 10, 2025 [1] Group 1: Subscription Details - The subscription shares account for approximately 1.81% of the enlarged issued share capital of the company [1] - The total proceeds from the subscription are expected to be around CAD 620,000, equivalent to approximately HKD 3.46 million [1] - After deducting related expenses, the net proceeds from the subscription are estimated to be about CAD 601,600, or approximately HKD 3.36 million [1] Group 2: Use of Proceeds - The net proceeds from the subscription will be used for general working capital [1] - The board believes that completing the subscription will provide a good opportunity for the company to raise surplus capital and strengthen its financial position [1] - The board also believes that the subscription will allow the company to acquire additional funds at a reasonable cost to support existing operations and further expand current and potential business and investment opportunities [1]

Core Viewpoint - The company, Kubo Medical-B (02216), has entered into a subscription agreement to issue and allot a total of 105 million subscription shares at a price of HKD 3.11 per share, which represents a premium over the market price on the date of the announcement [1] Group 1: Subscription Details - The total number of subscription shares to be issued represents approximately 16.60% of the enlarged issued share capital of the company, assuming no changes in the issued share capital from the date of the announcement until completion, except for the shares arising from the subscription [1] - The subscription price of HKD 3.11 per share is approximately 1.3% higher than the closing price of HKD 3.07 per share on the Hong Kong Stock Exchange on the date of the announcement [1] Group 2: Financial Implications - The estimated net proceeds from the subscription, after deducting expenses, are approximately HKD 327 million, equating to a net issue price of about HKD 3.106 per subscription share [1] - The net proceeds are intended to fund potential acquisitions in the medical device industry to continuously expand the company's product portfolio [1]

Core Viewpoint - The company, Kubo Medical-B (02216), has announced a subscription agreement to issue 105 million shares at a price of HKD 3.11 per share, which represents a premium over the market price on the announcement date [1] Summary by Relevant Categories Subscription Agreement - The company has conditionally agreed to issue a total of 105 million subscription shares [1] - The subscription price of HKD 3.11 per share is approximately 1.3% higher than the closing price of HKD 3.07 on the Hong Kong Stock Exchange on the announcement date [1] - The total number of shares to be issued represents about 16.60% of the enlarged issued share capital of the company, assuming no changes in the issued share capital until completion [1] Financial Implications - The estimated net proceeds from the subscription, after expenses, are approximately HKD 327 million, equating to a net issue price of about HKD 3.106 per share [1] - The net proceeds are intended to fund potential acquisitions in the medical device industry to continuously expand the product portfolio [1]

Share Issuance - On October 9, the company issued 669,493 new shares due to employees exercising the 2023 stock option plan at an exercise price of HKD 320.63 per share [1] - The total share capital increased from 9,153,003,220 shares to 9,153,672,713 shares [1] Share Buyback - The buyback period lasted from September 24 to October 9, totaling 10 trading days [1] - A total of 8,397,000 shares were repurchased, representing approximately 0.092% of the issued shares [1] - The buyback price ranged from HKD 641.65 to HKD 677.70 per share, with a single-day buyback on October 9 of 816,000 shares costing HKD 551 million [1] Buyback Authorization Status - The buyback authorization was approved on May 14, 2025 [1] - A total of 6,989,000 shares have been repurchased, accounting for 0.76% of the shares issued at the time of authorization [1] - There is a suspension period for new share issuance for 30 days following the buyback, lasting until November 8 [1]

Core Viewpoint - Neway Group (01686) announced the issuance of a total of 41,000 shares due to the exercise of stock options [1] Group 1 - The company has issued a total of 41,000 shares as a result of stock option exercises [1]

Core Viewpoint - China Financial Leasing (02312) has entered into a subscription agreement for the conditional subscription of 69.3795 million shares at a price of HKD 1.25 per share, which represents a discount of approximately 2.34% compared to the closing price of HKD 1.28 on October 3, 2025 [1] Group 1 - The total number of shares issued by the company as of the announcement date is 347 million [1] - The subscribed shares represent approximately 20% of the total shares issued as of the announcement date and approximately 16.67% of the total shares after the issuance of the subscribed shares, assuming no other changes in share capital from the announcement date to the completion date [1] - The expected total amount raised from the subscription is approximately HKD 86.7244 million, with a net amount of approximately HKD 86.4744 million [1]

Core Viewpoint - China Financial Leasing (02312) has entered into a conditional subscription agreement to issue 69.3795 million shares at a subscription price of HKD 1.25 per share, representing a discount of approximately 2.34% from the closing price of HKD 1.28 on October 3, 2025 [1] Summary by Sections Subscription Agreement - The subscription agreement was signed on October 5, 2025, with the subscriber agreeing to conditionally subscribe for shares [1] - The total number of shares to be issued is 69.3795 million [1] Share Capital and Ownership - As of the announcement date, the company has issued 347 million shares [1] - The newly issued shares will represent approximately 20% of the total shares already issued as of the announcement date and about 16.67% of the total shares after the issuance, assuming no other changes in share capital [1] Financial Implications - The expected total proceeds from the subscription are approximately HKD 86.7244 million, with a net amount of approximately HKD 86.4744 million [1]